The cash hiding in plain sight: how Procter & Gamble turned its supply chain into a weapon

Picture the scene: August 2012, and Bill Ackman's Pershing Square Capital Management has just disclosed a $1.8 billion stake in Procter & Gamble. Ackman is publicly calling for the removal of CEO Bob McDonald, arguing that the company has grown complacent and that margins have drifted well below what the business should be generating. The board is rattled. And somewhere in P&G's finance function, a quiet but consequential conversation is beginning about a number that rarely gets the attention it deserves: days payable outstanding.

What actually happened

P&G had for years operated with supplier payment terms that, by the standards of large consumer goods companies, were relatively generous. In 2013, the company announced it was extending those terms to 75 days, and in some cases further. The move was part of a broader working capitalworking capitalWorking capital is the difference between a company's current assets and current liabilities, measuring short-term liquidity and the funds available to run daily operations.View full definition → initiative that also included tightening inventory management across its global supply chain and accelerating collections from retail customers where possible.

The numbers that followed were notable. P&G's cash conversion cycle improved materially over the subsequent two years. Free cash flowFree cash flowFree Cash Flow is the cash a company generates from operations after funding the capital expenditures needed to maintain and grow its asset base.View full definition → productivity, a metric the company defines as free cash flow as a percentage of net earnings, climbed back above 90 percent and stayed there, well within the 90-100 percent range management had long cited as a target.

Crucially, P&G paired the payment extension with a supply chain financing program, often called dynamic discounting or reverse factoring. Suppliers who wanted early payment could get it, through a bank intermediary, at a cost of capital that reflected P&G's credit rating rather than their own. This meant smaller suppliers were not simply squeezed: they had an option. Whether that option was genuinely fair to smaller vendors is a legitimate debate, and critics of extended payment terms have consistently argued that the headline generosity of such programs masks real pressure on supplier margins. That argument is worth keeping in mind.

The activist context matters here. Ackman's campaign intensified through 2013 and into 2014, with Pershing Square publishing detailed analyses arguing that P&G's cost structure was bloated and its capital allocation was undisciplined. Working capital improvement was one of several responses management deployed alongside cost-cutting programs. McDonald was eventually replaced by A.G. Lafley in May 2013, and Lafley's team made free cash flow discipline a centerpiece of the recovery narrative presented to investors.

Why it still matters

The P&G episode crystallized something that finance teams had understood theoretically for decades but rarely acted on with the same urgency they applied to the income statement. Working capital is not a treasury housekeeping matter. It is a strategic variable that, when moved deliberately, can generate hundreds of millions in cash without touching revenue or EBITDAEBITDAEBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) measures a company's operating profitability before financing and accounting decisions, used to compare core performance across firms.View full definition →.

The math is simple enough that it is worth stating plainly. A company with $20 billion in annual cost of goods sold that extends its average payment terms from 45 days to 75 days releases approximately $1.6 billion in cash, all else equal. That cash can retire debt, fund buybacks, or simply reduce the company's dependence on revolving credit facilities. For a CFO facing an activist who is arguing the balance sheet is inefficiently managed, that is a meaningful and relatively fast response.

What P&G also demonstrated is that working capital moves are visible to sophisticated investors in a way that purely operational changes are not. Days sales outstanding, days inventory outstanding, and days payable outstanding are disclosed or calculable from public filings. Activists routinely benchmark these metrics against industry peers as part of their initial research. A company sitting at 35 days payable when its three main competitors average 60 days is, from an activist's perspective, a company with an obvious and quantifiable gap to close. It is, in short, a standing invitation.

The reverse factoring component added a layer of complexity that later became controversial at other companies. When Carillion collapsed in the UK in 2018, investigators found that supply chain finance had been used partly to obscure the true state of payables on the balance sheet, since reverse factoring liabilities were sometimes classified as trade payables rather than financial debt. The accounting treatment remains inconsistent across jurisdictions even in 2026, and CFOs should be clear-eyed about the disclosure obligations and reputational risk attached to these programs.

The takeaway for you

The durable lesson from the P&G moment is not that extending payment terms is always right, or that supply chain finance is always a useful tool. The lesson is about sequencing and framing.

When an activist arrives with a presentation arguing that your company's cash generation is suboptimal, the CFO needs to be able to answer three questions before the first board meeting: where exactly does your cash conversion cycle sit relative to peers, what specific levers are available to move it and on what timeline, and what is the cost, financial and relational, of pulling each one. If you cannot answer those questions fluently, you are already on the back foot.

P&G's finance team had those answers. The working capital program was not improvised in response to Ackman; the analytical groundwork existed, and management was able to articulate it credibly to investors. That credibility, more than any single financial metric, is what buys a CFO time when the shareholder base is restless.

Working capital optimization does not replace strategic vision, and a CFO who presents better payment terms as a substitute for genuine competitive improvement will not fool analysts for long. But as a component of a credible cash story told under pressure, it is one of the most concrete and defensible tools available.